SlideShare a Scribd company logo
1 of 63
Growth Charts
Dr Sujit K. Shrestha
Preview
History
Definition
Importance of Growth Monitoring
Types of Growth charts
Timing of Growth Monitoring
On going Studies and Projects
Software available.
History - Innovation
• The idea of plotting a child’s body measurements on a chart
to illustrate their pattern of growth first - Count Philibert de
Montbeillard (1720-1785)
• George Buffon (1707-1788) 
published the chart in his Histoire
Naturelle, thus producing the first
height growth curve
(Tanner 1962).
George Buffon, France
20th Century
Effort to Standardize
• Until the late 1970s, clinicians used various
growth charts to assess child growth.
• No uniform measurement methods
• Efforts were made to create a standard growth
chart that could be used for all population.
Growth
a net increase in size or mass of tissues as a result of either
multiplication of cells or increase in intracellular substance.
- hypertrophy and/or hyperplasia of cells
• Fetal growth  by fetal, placental and maternal factors.
• Under normal environment fetus grows as per its inherent growth
potential to an appropriate size newborn.
• Post-natal growth  genetic potential and various
internal and external factors.
• Therefore growth monitoring important to detect
deviation from normal
Definition: Growth Chart
• A growth chart is a graphic design of a growth reference
presented as a visual display for clinical use.
• comprise growth curves which display both the size of
the newborn at a series of ages, and at the same time
their growth rate or growth velocity over time, based
on the slope of the curve.
• the charts have become an important tool in child health
screening and pediatric clinical workup.
Growth Reference
• A statistical summary of anthropometry in a reference group
of children
• usually presented as the frequency distribution at different
ages.
• representative of some geographic region at a particular
time, e.g. Great Britain in 1990
• involves the mean and SD or alternatively the median and
selected centiles, conditioned (usually) on age and sex.
• it describe how children grow
• To establish whether or not their measurements are
typical of the reference group.
Growth Standard
• A growth standard is essentially the same as a growth
reference except that the underlying reference sample is
selected on health grounds.
• represents a healthy pattern of growth
• the standard shows how children ought to grow rather
than how they do grow.
• Eg WHO MGRS Growth standards
Difference
Reference charts Standard charts
Simply describes the growth of a
population without taking into the
consideration the health of the
population.
Provides guidance on how a child should
grow not just how child is growing.
Based on cross sectional data, relatively
easy to acquire large sample size
Based on prospective and longitudinal
monitoring of healthy growth; and diffi
cult to acquire large sample size.
Increase in incidence of childhood
obesity means future descriptive charts
will enable more children to be classified
as normal even though overweight and
obese.
Have the potential to diagnose over
weight and obesity early which can help
in early intervention.
Have the potential to over diagnose
under nutrition which in turn can lead to
overfeeding
Have the potential to avoid over
diagnosis of under nutrition.
Centile and Z score
The centile for an individual indicates his or her size, be it
height, weight or body mass index etc. The centile indicates
the distance they have travelled along the growth road up to
that age. The growth chart quantifies size/distance in terms
of the centile.
Z scrores-. For population-based assessment—including
surveys and nutritional surveillance—the Z-score is widely
recognized as the best system for analysis and presentation
of anthropometric data because of its advantages compared
to the other methods.
Z-score (or SD-score) = (observed value - median value of the
reference population) / standard deviation value of reference
population
Interpreting the results in terms of Z-scores has several
advantages:
• same statistical relation to the distribution of the reference
around the mean at all ages, which makes results comparable
across ages groups and indicators.
• Z-scores are also sex-independent, thus permitting the
evaluation of children's growth status by combining sex and
age groups.
• These characteristics of Z-scores allow further computation of
summary statistics such as means, standard deviations, and
standard error to classify a population's growth status.
• Furthermore, individuals whose growth curve tracks
along the centiles over time are growing at average
velocity, while if the curve crosses centiles up or down
the individual is growing faster or slower than average –
centile crossing is a measure of relative velocity.
• A growth chart visualizes growth velocity, but it does not
quantify it – centile crossing is uncalibrated.
Growth velocity
• With exponential growth, the logarithm of weight results in a
linear function whose slope is equal to the growth velocity.
The growth velocity (GV) between two different days, in terms
of g/kg/day, can be determined with the following equation:
•
• where W1 is the weight (in grams) at the first day (D1) and W2
is the weight at the second day (D2). When exponential
growth is considered-
Anthropometric measurements
Length measurement
Instrument- Infantometer
Measurement of Weight
Instrument used-
• Measurement of weight in this population should be
taken on a scale that has been properly calibrated.
• The infant should be weighed without clothing or diaper.
Head circumference
• flexible tape
• measure at the maximum diameter through the
supraorbital ridge to the occiput.
• The value should be reported to the nearest 0.01 cm
Growth Charts:
Intrauterine Growth Charts Post-natal growth charts
Battaglia and Lubchenco 1967
Usher and Maclean 1969
Babson and Benda 1976
Fenton 2003
Fenton 2013
Berry et al 1997
Ehrenkranz 1999
CDC 2000
WHO 2006
Intergrowth 21st 2014
Intrauterine Growth Charts
• Over dozen published world wide
• Only few includes weight, length, and HC
• USA (Lubchenco 1966)
• Canada (Usher & McLean 1969)
• South Wales (Beeby 1996)
• Sweden (Niklasson 1991)
• South Wales/Sweden/Canada (Fenton 2003)
• USA (Olsen 2010)
Handbook of Growth and Growth Monitoring in Health and Disease
edited by Victor R. Preedy
Limitations of Growth charts
Limitation of available Intra
Uterine growth charts
• Small sample size
• Not being gender specific
• Used LMP as mean of Gestation age- 40% error caused
by maternal factors
• Do not describe longitudinal fetal growth.
• Preterm infant is inherently different from fetus, so
concerns about using IU charts as standards.
Importance of Growth monitoring
specially in Preterm infants
• During Hospital stay
• Rapid gain- Fluid overload, catch-up
• Low gain- inadequate nutrition, illnesses
• Neurodevelopmental effects
• Standard formula vs Preterm enriched formula
observation
• Erenkranz’s observation
• Metabolic effect
• Overweight , obesity
• Metabolic syndrome
Lubchenco 1967
Study Multicenter, Retrospective study.
Population Full-Term and Premature Infant Nurseries
from July, 1948, to January, 1961
Size- 5635
Low socio-economic status
White and Hispanic
Centre Colorado General Hospital ,USA High Altitude
Duration Between August 31, 1994 and August 9, 1995
26-42 weeks POG
Measurements Body weight, length, head circumference, and
weight-length ratio- Ponderal Index.
Data type Cross Sectional
Lubchenco
Benefits • Used Ponderal Index, a new parameter in
charts
• A better accepted chart than previous models
• In conjunction with intrauterine weight charts,
permit the identification of infants with
unusual intrauterine growth patterns.
• aid in the design of future research.
Drawbacks Charts of intrauterine growth in length, HC ,
weight, and weight-length ratio are only
approximate definitions of the group pattern of
fetal growth with gestational age.
Population based on only one country and of high
altitude.
Advice
Pediatrics. 1999 Aug;104(2 Pt 1):280-9.
Longitudinal growth of hospitalized very low birth weight infants. Ehrenkranz RA1, Younes
N, Lemons JA, Fanaroff AA,
Ehrenkranz 1999
Study Large, multicenter, prospective cohort study.
Population 1660 infants with birth weights between 501 to
1500 g admitted by 24 hours of age, included if
they survived >7 days (168 hours) and were
free of major congenital anomalies.
Centre 12 NICHHD Neonatal Research Network
centers, USA
Duration Between August 31, 1994 and August 9, 1995
Measurements Body weight, length, head circumference, and
MAC
Endpoint discharge, transfer, death, 120 days, or body
weight of 2000 g
Data type Longitudinal data
Erenkranz
Benefits • These growth curves  better understand
postnatal growth
• help identify infants developing illnesses
affecting growth,
• aid in the design of future research.
Drawbacks Cannot be taken as optimal.
Small Sample Size
Single Population- so cannot be used for world
population.
It is limited by the lack of data describing daily
caloric and nutritional intake, therefore, growth
could not be correlated with nutritional intake
Advice Further RCTs on factors affecting postnatal growth-
Calorie
Pediatrics. 1999 Aug;104(2 Pt 1):280-9.
Longitudinal growth of hospitalized very low birth weight infants. Ehrenkranz RA1, Younes
N, Lemons JA, Fanaroff AA,
Babson and Benda chart
• The growth chart by Babson and Benda (1976) shows means and
standard deviations for birth weight, head circumference, and
length from a gestational age of 26 weeks to 1 year of age.
• For the newborns, Babson obtained data from mostly Caucasian
infants born in Portland, Oregon, for the years from 1959
through 1966.
• 39,743 infants with gestational ages from 27 to 44 weeks,
including 3381 infants with gestational ages from 27 to 37 weeks
were included in the study.
• The gestational age was based on the LMP.
• Mean and standard deviation for 3 parameters were measured
from the chart and were converted into percentiles.
Babson and Benda
• Limitations-
• X axis begins at 26 weeks gestation- limits plotting
younger preterms
• Y axis has 500gm interval increments-Precise plotting
difficult
• Small sample size with only 45 babies of 30 weeks or
lesser gestation.
• 15 years old at time of creating charts and now >50
years old
Fenton 2003
Study Meta-analysis of Studies
Population The Newborn parameters were based on
a. Birth weight- Kramer et al 2001 . USG was used
in estimating Gestation age, CDC
b. Length and head circumference- Niklasson and
Beeby. Gestation- LMP and obstetric
assessment.
Gestation age between 22 and 50 weeks.
Centre Calgary,Canada.
Duration 1980 to 2002
Measurements Weight, length and head circumference
Data type Cross sectional data predominantly
FENTO
N
Benefits 1. This new fetal-infant chart- updated Babson type
2. This chart will allow a comparison for preterm
infants as young as 22 weeks of gestation first with
intrauterine and then with post term references and
it can replace the one developed by Babson which
has been used in neonatal intensive care for over 25
years.
3. The larger sample sizes and more accurate
gestational age assignments used here may provide
better confidence in the extreme percentiles.
4. It could be used for the assessment of size for
gestational age for infants smaller than 2 kilograms.
5. Shows 3, 10, 25, 50, 90 and 97 th Percentiles
Disadvantages:
1. Initial parts of the curves are based on the size of fetuses at
birth, which do not show the change in weight that occurs
after birth.
2. This is followed by curves based on the growth of term
infants who have not had the growth depressing effect of
prematurity.
3. Predominantly data were cross sectional.- Longitudinal
postnatal growth chart- show the pattern of initial weight
loss after birth followed by subsequent growth of a sample of
preterm infants.
Disadvantages:
4. Not based on the growth standard for preterm infants,
that is, on fetal growth. Therefore they do not show an
infant’s growth velocity or catch-up in growth relative to
the fetus or the term infant.
5. Further, the curves on a longitudinal growth chart are
highly influenced by the medical and nutritional care of
the sample infants; growth patterns may change with
innovations in medical and nutritional care
6. Like with all metanalysis , heterogenesity of data
sources is a set back.
WHO MCGS 2006
Study Recent population based surveys
Population The 2006 WHO growth curves for children are based
on data from the WHO MGRS, a study conducted in
six sites: Pelotas, Brazil; Accra, Ghana; Delhi, India;
Oslo, Norway; Muscat, Oman; and Davis, California.
Centre Multi-centric
Duration 1997-2003
Measurements weight, length and head circumference
Data type Longitudinal data
Continued
Benefits 1. Children from socioeconomic status that does not constrain
growth of the child*
2. Six Countries from different continents including both
developed and developing countries.
3. Based on population of breast fed babies. The international
infant feeding recommendations in effect at the time of the
study included exclusive breastfeeding for at least 4 months
(although predominantly breastfed infants were also included in
the study)#
4. The WHO growth curves for children aged <24 months were
based on the longitudinal component of MGRS, in which cohorts
of newborns were measured from birth through age 23 months.
Longitudinal data were collected at birth, 1 week, and every 2
weeks for the fi rst 2 months after birth, monthly through age 12
months, and bimonthly from age 14 to 24 months
Continued
Benefits 15. The WHO growth curves for children aged 24-59 months were
based on the cross-sectional component MGRS, in which groups
of children at specifi c ages were measured at a specifi c point in
time. The crosssectional data represented 6,669 children.
6. Data were collected in the same communities as those used to
create the curves for children aged <24 months, typically just
after completion of the longitudinal study.
7. Other than the infant feeding criteria, the inclusion criteria
used for the cross-sectional data collection for ages <24 months
and 24-59 months were the same.
8. To eliminate the effect of overweight children on the weight
distributions in the WHO curves for children aged 24-59 months,
weight measurements of >2 standard deviations above the study
median were excluded; a total of 226 (2.7%) weight
measurements were excluded.
Disadvantages:
- Does not address Growth of Preterm infants.
Fenton 2013
Study Metanalysis of studies
Population Large preterm birth sample size of 4 million infants
Data from developed countries including Germany,
Italy, United States, Australia, Scotland and Canada
Centre Alberta, Canada.
Duration 1991 to 2007
Measurements of weight, length and head circumference
Data type Cross sectional data for Preterm infants
Continued
Benefits 1. Based on the recommended growth goal
for preterm infants: The fetus and the
term infant
2. Girl and boy specific charts
3. Equivalent to the WHO growth charts at
50 weeks gestational age (10 weeks post
term age).
4. Large Sample size of 4 million, with large
preterm population.
5. More recent Data ( 1991-2007)
FENTON
Benefits 1. Data from several Developed nations- can be
used for both developing and developed.
2. Curves are consistent with the data to 36 weeks,
thus can be used to assign size for gestational
age up to and including 36 weeks.
3. Chart is designed to enable plotting as infants
are measured, not as completed weeks. The x
axis adjusted for this chart so that infant size
data can be plotted without age adjustment
Disadvantages:
1. These growth charts are growth references and are not a
growth standard
2. Ideal growth pattern of preterm remains undefined as charts
were based on fetal growth and term babies.
Intergrowth 21st Chart:
For the first time (panel), international standards for newborn
size for each gestational age based on data from its NCSS
subpopulation, which conformed at population and individual
levels to the prescriptive approach used in the WHO MGRS.
1. These new standards - conceptual and practical link to WHO
Child Growth Standards, which have been adopted by more than
125 countries worldwide.
2. Gestation age based on USG
3. Included 20,486 eligible women between May 14, 2009, and
Aug 2, 2013.
4. Bridges gaps in clinical and population assessments for fetuses,
neonatal babies, and infants through provision of similar
instruments to monitor child growth seamlessly from early
pregnancy to age 5 years and to screen for stunting and wasting.
5 Studies are included in the
Project
• Fetal Longitudinal Growth Study - a multicentric, population-
based assessment of fetal growth in eight countries.
• USG was taken for fetal anthropometric measurements
prospectively from 14+0 weeks gestation until birth in a
cohort of women. women had a reliable estimate of
gestational age confirmed by USG measurement of fetal
crown–rump length in the first trimester.
• The five primary ultrasound measures were obtained every 5
weeks (within 1 week either side) from 14 weeks to 42 weeks
of gestation.
• The best fitting curves for the five measures were selected
using second-degree fractional polynomials and further
modelled in a multilevel framework to account for the
longitudinal design of the study.
• A total 4607 eligible women were included.
• A cohort of women with adequate nutrition and health status
with less risk of intrauterine growth restriction were selected.
• All women had reliable estimate of gestational age confirmed
by USG. A 3rd, 5th 10th, 50th, 90th, 95th and 97th centile
curves according to gestational age for these ultrasound
measures were obtained, representing the international
standards for fetal growth .
• These international fetal growth standards for the clinical
interpretation of routinely taken ultrasound measurements
and for comparisons across populations.
PPFS and NCSS
• For Preterm Postnatal Follow-up Study, all preterm newborns
of more than 26 weeks and less than 37 weeks were followed
post-delivery for evaluation of postnatal growth. All preterms
from FLGS who met criteria of healthy or stable preterm were
included.
• The Newborn Cross-Sectional Study, a component of
intergrowth-21st project, weight, length, and head
circumference in all newborn infants were measured, in
addition to the data collected prospectively for pregnancy and
the perinatal period. Newborn anthropometric measures were
obtained within 12 h of birth. A total of 20,486 eligible
women were enrolled between May 14, 2009, and Aug 2,
2013. A 3rd, 10th, 50th, 90th, and 97th centile curves were
obtained according to gestational age and sex.
5. Software for clinical and epidemiological use free of charge,
including an app to calculate Z scores and centiles.
6. The standards are prescriptive—ie, they describe optimum
size in newborn infants without congenital abnormalities.
7. These standards are population-based, multiethnic,
multicountry, and sex-specific, and they arise from a
prospective study.
8.Several processes were applied across all eight study
sites— All were uniform and followed a standarized
protocol.
9. Present centiles for birthweight, length, and head
circumference by sex and gestational age based on a
prescriptive approach that are integrated with the
corresponding fetal growth standards.
10. The observed and smoothed centiles were almost
identical and presented the 3rd, 10th, 50th, 90th, and 97th
centile curves according to gestational age and sex.
Disadvantages
• A shortcoming of studying such a low-risk group is that there
were relatively few early preterm births despite the large
sample size; hence, we had to limit the range of the standards
by setting the lower limit of the curves to those born at 33
weeks of gestation.
• It might not be feasible to construct standards for very
preterm newborn infants using such a strictly defined
subpopulation of preterm babies who are at higher risk of
intrauterine growth restriction and other major pregnancy and
neonatal complications
Time Schedule for Monitoring
• Sri Lanka becomes the first country to adopt the
INTERGROWTH-21st Preterm Standards
• 125 nations have adopted so far
THANK YOU
• THE END

More Related Content

What's hot

Follow up of High Risk Neonates.. Dr.Padmesh
Follow up of High Risk Neonates.. Dr.Padmesh Follow up of High Risk Neonates.. Dr.Padmesh
Follow up of High Risk Neonates.. Dr.Padmesh Dr Padmesh Vadakepat
 
Approach to neonatal anemia
Approach to neonatal anemiaApproach to neonatal anemia
Approach to neonatal anemiaChandan Gowda
 
Surfactant replacement therapy : RDS & beyond
Surfactant replacement therapy : RDS & beyondSurfactant replacement therapy : RDS & beyond
Surfactant replacement therapy : RDS & beyondDr-Hasen Mia
 
Infant of diabetic mother
Infant of diabetic motherInfant of diabetic mother
Infant of diabetic motherSayed Ahmed
 
Treatment of neonatal hypoglycemia
Treatment of neonatal hypoglycemia  Treatment of neonatal hypoglycemia
Treatment of neonatal hypoglycemia mandar haval
 
Epilepsy mimics in childern
Epilepsy mimics in childernEpilepsy mimics in childern
Epilepsy mimics in childernAmr Hassan
 
Approach to tall stature
Approach to tall statureApproach to tall stature
Approach to tall statureDr Inayat Ullah
 
Approach to neuroregression
Approach to neuroregressionApproach to neuroregression
Approach to neuroregressiondrswarupa
 
Neonatal shock
Neonatal shockNeonatal shock
Neonatal shock. .
 
Bronchopulmonary dysplasia updates_and_prevention dr falakha
Bronchopulmonary dysplasia updates_and_prevention dr falakhaBronchopulmonary dysplasia updates_and_prevention dr falakha
Bronchopulmonary dysplasia updates_and_prevention dr falakhagfalakha
 
approach to short stature
approach to short statureapproach to short stature
approach to short statureRatnakar Vallem
 
Approach to anemia in children
Approach to anemia in childrenApproach to anemia in children
Approach to anemia in childrenvinay nandimalla
 
Neonatal hypoglycemia
Neonatal hypoglycemia Neonatal hypoglycemia
Neonatal hypoglycemia Azad Haleem
 
Approach to Milestone Regression
Approach to Milestone RegressionApproach to Milestone Regression
Approach to Milestone RegressionNeurologyKota
 
Growth assessment and monitoring
Growth assessment and monitoringGrowth assessment and monitoring
Growth assessment and monitoringTauhid Iqbali
 
Transient tachypnea of newborn ttn
Transient tachypnea of newborn ttnTransient tachypnea of newborn ttn
Transient tachypnea of newborn ttnTarek Kotb
 
Neonatal hypoglycemia
Neonatal hypoglycemia Neonatal hypoglycemia
Neonatal hypoglycemia Amlendra Yadav
 

What's hot (20)

Follow up of High Risk Neonates.. Dr.Padmesh
Follow up of High Risk Neonates.. Dr.Padmesh Follow up of High Risk Neonates.. Dr.Padmesh
Follow up of High Risk Neonates.. Dr.Padmesh
 
Pediatric ARDS
Pediatric ARDSPediatric ARDS
Pediatric ARDS
 
Approach to neonatal anemia
Approach to neonatal anemiaApproach to neonatal anemia
Approach to neonatal anemia
 
Surfactant replacement therapy : RDS & beyond
Surfactant replacement therapy : RDS & beyondSurfactant replacement therapy : RDS & beyond
Surfactant replacement therapy : RDS & beyond
 
Infant of diabetic mother
Infant of diabetic motherInfant of diabetic mother
Infant of diabetic mother
 
Treatment of neonatal hypoglycemia
Treatment of neonatal hypoglycemia  Treatment of neonatal hypoglycemia
Treatment of neonatal hypoglycemia
 
Epilepsy mimics in childern
Epilepsy mimics in childernEpilepsy mimics in childern
Epilepsy mimics in childern
 
Approach to tall stature
Approach to tall statureApproach to tall stature
Approach to tall stature
 
Approach to neuroregression
Approach to neuroregressionApproach to neuroregression
Approach to neuroregression
 
Neonatal shock
Neonatal shockNeonatal shock
Neonatal shock
 
Bronchopulmonary dysplasia updates_and_prevention dr falakha
Bronchopulmonary dysplasia updates_and_prevention dr falakhaBronchopulmonary dysplasia updates_and_prevention dr falakha
Bronchopulmonary dysplasia updates_and_prevention dr falakha
 
approach to short stature
approach to short statureapproach to short stature
approach to short stature
 
Approach to anemia in children
Approach to anemia in childrenApproach to anemia in children
Approach to anemia in children
 
OSCE Pediatrics
OSCE PediatricsOSCE Pediatrics
OSCE Pediatrics
 
Neonatal hypoglycemia
Neonatal hypoglycemia Neonatal hypoglycemia
Neonatal hypoglycemia
 
Neonatal Cholestasis
Neonatal CholestasisNeonatal Cholestasis
Neonatal Cholestasis
 
Approach to Milestone Regression
Approach to Milestone RegressionApproach to Milestone Regression
Approach to Milestone Regression
 
Growth assessment and monitoring
Growth assessment and monitoringGrowth assessment and monitoring
Growth assessment and monitoring
 
Transient tachypnea of newborn ttn
Transient tachypnea of newborn ttnTransient tachypnea of newborn ttn
Transient tachypnea of newborn ttn
 
Neonatal hypoglycemia
Neonatal hypoglycemia Neonatal hypoglycemia
Neonatal hypoglycemia
 

Similar to Growth charts in Neonates- Preterm and term

WHO Growth Chart
WHO Growth ChartWHO Growth Chart
WHO Growth ChartKunal Modak
 
assessment of growth and development.pptx
assessment of growth and development.pptxassessment of growth and development.pptx
assessment of growth and development.pptxNithinKumar188
 
IAP Growth Monitoring Guidelines for Children from Birth to 18 Years
IAP Growth Monitoring Guidelines for Children from Birth to 18 YearsIAP Growth Monitoring Guidelines for Children from Birth to 18 Years
IAP Growth Monitoring Guidelines for Children from Birth to 18 Yearsmandar haval
 
Physical Examination
Physical  ExaminationPhysical  Examination
Physical Examinationdocanto
 
Seminar short stature
Seminar short statureSeminar short stature
Seminar short statureRakesh Verma
 
Growth monitoring, screening and survillence
Growth monitoring, screening and survillenceGrowth monitoring, screening and survillence
Growth monitoring, screening and survillenceRakesh Verma
 
Assessment of Nutritional Status.pptx
Assessment of Nutritional Status.pptxAssessment of Nutritional Status.pptx
Assessment of Nutritional Status.pptxyetundealozie
 
Module 1: Pediatric Growth Assessment Part 1: The Principles
Module 1: Pediatric Growth Assessment Part 1: The PrinciplesModule 1: Pediatric Growth Assessment Part 1: The Principles
Module 1: Pediatric Growth Assessment Part 1: The PrinciplesNutrition Resource Centre
 
Growth measures in Clinical Practice
Growth measures in Clinical PracticeGrowth measures in Clinical Practice
Growth measures in Clinical PracticeMohan Shenoy
 
Antrhropometry lec 4th sem HND.pptx
Antrhropometry lec 4th sem HND.pptxAntrhropometry lec 4th sem HND.pptx
Antrhropometry lec 4th sem HND.pptxShafaatHussain20
 

Similar to Growth charts in Neonates- Preterm and term (20)

Growth charts
Growth chartsGrowth charts
Growth charts
 
Who growth chart
Who growth chartWho growth chart
Who growth chart
 
WHO Growth Chart
WHO Growth ChartWHO Growth Chart
WHO Growth Chart
 
Growh charts by praman
Growh charts by pramanGrowh charts by praman
Growh charts by praman
 
Growthcharts
GrowthchartsGrowthcharts
Growthcharts
 
assessment of growth and development.pptx
assessment of growth and development.pptxassessment of growth and development.pptx
assessment of growth and development.pptx
 
IAP Growth Monitoring Guidelines for Children from Birth to 18 Years
IAP Growth Monitoring Guidelines for Children from Birth to 18 YearsIAP Growth Monitoring Guidelines for Children from Birth to 18 Years
IAP Growth Monitoring Guidelines for Children from Birth to 18 Years
 
Physical Examination
Physical  ExaminationPhysical  Examination
Physical Examination
 
Seminar short stature
Seminar short statureSeminar short stature
Seminar short stature
 
Growth monitoring, screening and survillence
Growth monitoring, screening and survillenceGrowth monitoring, screening and survillence
Growth monitoring, screening and survillence
 
Assessment of Nutritional Status.pptx
Assessment of Nutritional Status.pptxAssessment of Nutritional Status.pptx
Assessment of Nutritional Status.pptx
 
Growth monitoring
Growth monitoringGrowth monitoring
Growth monitoring
 
Growth chart
Growth chartGrowth chart
Growth chart
 
Module 1: Pediatric Growth Assessment Part 1: The Principles
Module 1: Pediatric Growth Assessment Part 1: The PrinciplesModule 1: Pediatric Growth Assessment Part 1: The Principles
Module 1: Pediatric Growth Assessment Part 1: The Principles
 
Growth chart
Growth chartGrowth chart
Growth chart
 
Technique of assessment of growth
Technique of assessment of growthTechnique of assessment of growth
Technique of assessment of growth
 
Nutritional status of infants
Nutritional status of infantsNutritional status of infants
Nutritional status of infants
 
Growth measures in Clinical Practice
Growth measures in Clinical PracticeGrowth measures in Clinical Practice
Growth measures in Clinical Practice
 
Growth monitor
Growth monitorGrowth monitor
Growth monitor
 
Antrhropometry lec 4th sem HND.pptx
Antrhropometry lec 4th sem HND.pptxAntrhropometry lec 4th sem HND.pptx
Antrhropometry lec 4th sem HND.pptx
 

More from Sujit Shrestha

HIE Birth asphyxia in Neonates
HIE Birth asphyxia in NeonatesHIE Birth asphyxia in Neonates
HIE Birth asphyxia in NeonatesSujit Shrestha
 
Pphn in neonates: Updates on management
Pphn in neonates: Updates on managementPphn in neonates: Updates on management
Pphn in neonates: Updates on managementSujit Shrestha
 
An approach to a Floppy infant - Dr Sujit
An approach to a Floppy infant - Dr SujitAn approach to a Floppy infant - Dr Sujit
An approach to a Floppy infant - Dr SujitSujit Shrestha
 
Antibiotic Uses in Neonates
Antibiotic Uses in NeonatesAntibiotic Uses in Neonates
Antibiotic Uses in NeonatesSujit Shrestha
 
Newer antibiotics and uses
Newer antibiotics and usesNewer antibiotics and uses
Newer antibiotics and usesSujit Shrestha
 

More from Sujit Shrestha (8)

HIE Birth asphyxia in Neonates
HIE Birth asphyxia in NeonatesHIE Birth asphyxia in Neonates
HIE Birth asphyxia in Neonates
 
Vaccines in children
Vaccines in childrenVaccines in children
Vaccines in children
 
Bleeding ii
Bleeding iiBleeding ii
Bleeding ii
 
Pphn in neonates: Updates on management
Pphn in neonates: Updates on managementPphn in neonates: Updates on management
Pphn in neonates: Updates on management
 
Neonatal ventilation
Neonatal ventilationNeonatal ventilation
Neonatal ventilation
 
An approach to a Floppy infant - Dr Sujit
An approach to a Floppy infant - Dr SujitAn approach to a Floppy infant - Dr Sujit
An approach to a Floppy infant - Dr Sujit
 
Antibiotic Uses in Neonates
Antibiotic Uses in NeonatesAntibiotic Uses in Neonates
Antibiotic Uses in Neonates
 
Newer antibiotics and uses
Newer antibiotics and usesNewer antibiotics and uses
Newer antibiotics and uses
 

Recently uploaded

History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 

Recently uploaded (20)

History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 

Growth charts in Neonates- Preterm and term

  • 2. Preview History Definition Importance of Growth Monitoring Types of Growth charts Timing of Growth Monitoring On going Studies and Projects Software available.
  • 3. History - Innovation • The idea of plotting a child’s body measurements on a chart to illustrate their pattern of growth first - Count Philibert de Montbeillard (1720-1785) • George Buffon (1707-1788)  published the chart in his Histoire Naturelle, thus producing the first height growth curve (Tanner 1962). George Buffon, France
  • 4. 20th Century Effort to Standardize • Until the late 1970s, clinicians used various growth charts to assess child growth. • No uniform measurement methods • Efforts were made to create a standard growth chart that could be used for all population.
  • 5. Growth a net increase in size or mass of tissues as a result of either multiplication of cells or increase in intracellular substance. - hypertrophy and/or hyperplasia of cells • Fetal growth  by fetal, placental and maternal factors. • Under normal environment fetus grows as per its inherent growth potential to an appropriate size newborn. • Post-natal growth  genetic potential and various internal and external factors. • Therefore growth monitoring important to detect deviation from normal
  • 6. Definition: Growth Chart • A growth chart is a graphic design of a growth reference presented as a visual display for clinical use. • comprise growth curves which display both the size of the newborn at a series of ages, and at the same time their growth rate or growth velocity over time, based on the slope of the curve. • the charts have become an important tool in child health screening and pediatric clinical workup.
  • 7. Growth Reference • A statistical summary of anthropometry in a reference group of children • usually presented as the frequency distribution at different ages. • representative of some geographic region at a particular time, e.g. Great Britain in 1990 • involves the mean and SD or alternatively the median and selected centiles, conditioned (usually) on age and sex. • it describe how children grow • To establish whether or not their measurements are typical of the reference group.
  • 8. Growth Standard • A growth standard is essentially the same as a growth reference except that the underlying reference sample is selected on health grounds. • represents a healthy pattern of growth • the standard shows how children ought to grow rather than how they do grow. • Eg WHO MGRS Growth standards
  • 9. Difference Reference charts Standard charts Simply describes the growth of a population without taking into the consideration the health of the population. Provides guidance on how a child should grow not just how child is growing. Based on cross sectional data, relatively easy to acquire large sample size Based on prospective and longitudinal monitoring of healthy growth; and diffi cult to acquire large sample size. Increase in incidence of childhood obesity means future descriptive charts will enable more children to be classified as normal even though overweight and obese. Have the potential to diagnose over weight and obesity early which can help in early intervention. Have the potential to over diagnose under nutrition which in turn can lead to overfeeding Have the potential to avoid over diagnosis of under nutrition.
  • 10. Centile and Z score The centile for an individual indicates his or her size, be it height, weight or body mass index etc. The centile indicates the distance they have travelled along the growth road up to that age. The growth chart quantifies size/distance in terms of the centile. Z scrores-. For population-based assessment—including surveys and nutritional surveillance—the Z-score is widely recognized as the best system for analysis and presentation of anthropometric data because of its advantages compared to the other methods.
  • 11. Z-score (or SD-score) = (observed value - median value of the reference population) / standard deviation value of reference population Interpreting the results in terms of Z-scores has several advantages: • same statistical relation to the distribution of the reference around the mean at all ages, which makes results comparable across ages groups and indicators. • Z-scores are also sex-independent, thus permitting the evaluation of children's growth status by combining sex and age groups. • These characteristics of Z-scores allow further computation of summary statistics such as means, standard deviations, and standard error to classify a population's growth status.
  • 12. • Furthermore, individuals whose growth curve tracks along the centiles over time are growing at average velocity, while if the curve crosses centiles up or down the individual is growing faster or slower than average – centile crossing is a measure of relative velocity. • A growth chart visualizes growth velocity, but it does not quantify it – centile crossing is uncalibrated.
  • 13. Growth velocity • With exponential growth, the logarithm of weight results in a linear function whose slope is equal to the growth velocity. The growth velocity (GV) between two different days, in terms of g/kg/day, can be determined with the following equation: • • where W1 is the weight (in grams) at the first day (D1) and W2 is the weight at the second day (D2). When exponential growth is considered-
  • 15. Measurement of Weight Instrument used- • Measurement of weight in this population should be taken on a scale that has been properly calibrated. • The infant should be weighed without clothing or diaper.
  • 16. Head circumference • flexible tape • measure at the maximum diameter through the supraorbital ridge to the occiput. • The value should be reported to the nearest 0.01 cm
  • 17. Growth Charts: Intrauterine Growth Charts Post-natal growth charts Battaglia and Lubchenco 1967 Usher and Maclean 1969 Babson and Benda 1976 Fenton 2003 Fenton 2013 Berry et al 1997 Ehrenkranz 1999 CDC 2000 WHO 2006 Intergrowth 21st 2014
  • 18. Intrauterine Growth Charts • Over dozen published world wide • Only few includes weight, length, and HC • USA (Lubchenco 1966) • Canada (Usher & McLean 1969) • South Wales (Beeby 1996) • Sweden (Niklasson 1991) • South Wales/Sweden/Canada (Fenton 2003) • USA (Olsen 2010)
  • 19. Handbook of Growth and Growth Monitoring in Health and Disease edited by Victor R. Preedy
  • 21. Limitation of available Intra Uterine growth charts • Small sample size • Not being gender specific • Used LMP as mean of Gestation age- 40% error caused by maternal factors • Do not describe longitudinal fetal growth. • Preterm infant is inherently different from fetus, so concerns about using IU charts as standards.
  • 22. Importance of Growth monitoring specially in Preterm infants • During Hospital stay • Rapid gain- Fluid overload, catch-up • Low gain- inadequate nutrition, illnesses • Neurodevelopmental effects • Standard formula vs Preterm enriched formula observation • Erenkranz’s observation • Metabolic effect • Overweight , obesity • Metabolic syndrome
  • 23. Lubchenco 1967 Study Multicenter, Retrospective study. Population Full-Term and Premature Infant Nurseries from July, 1948, to January, 1961 Size- 5635 Low socio-economic status White and Hispanic Centre Colorado General Hospital ,USA High Altitude Duration Between August 31, 1994 and August 9, 1995 26-42 weeks POG Measurements Body weight, length, head circumference, and weight-length ratio- Ponderal Index. Data type Cross Sectional
  • 24. Lubchenco Benefits • Used Ponderal Index, a new parameter in charts • A better accepted chart than previous models • In conjunction with intrauterine weight charts, permit the identification of infants with unusual intrauterine growth patterns. • aid in the design of future research. Drawbacks Charts of intrauterine growth in length, HC , weight, and weight-length ratio are only approximate definitions of the group pattern of fetal growth with gestational age. Population based on only one country and of high altitude. Advice
  • 25. Pediatrics. 1999 Aug;104(2 Pt 1):280-9. Longitudinal growth of hospitalized very low birth weight infants. Ehrenkranz RA1, Younes N, Lemons JA, Fanaroff AA,
  • 26. Ehrenkranz 1999 Study Large, multicenter, prospective cohort study. Population 1660 infants with birth weights between 501 to 1500 g admitted by 24 hours of age, included if they survived >7 days (168 hours) and were free of major congenital anomalies. Centre 12 NICHHD Neonatal Research Network centers, USA Duration Between August 31, 1994 and August 9, 1995 Measurements Body weight, length, head circumference, and MAC Endpoint discharge, transfer, death, 120 days, or body weight of 2000 g Data type Longitudinal data
  • 27. Erenkranz Benefits • These growth curves  better understand postnatal growth • help identify infants developing illnesses affecting growth, • aid in the design of future research. Drawbacks Cannot be taken as optimal. Small Sample Size Single Population- so cannot be used for world population. It is limited by the lack of data describing daily caloric and nutritional intake, therefore, growth could not be correlated with nutritional intake Advice Further RCTs on factors affecting postnatal growth- Calorie Pediatrics. 1999 Aug;104(2 Pt 1):280-9. Longitudinal growth of hospitalized very low birth weight infants. Ehrenkranz RA1, Younes N, Lemons JA, Fanaroff AA,
  • 28.
  • 29.
  • 30. Babson and Benda chart • The growth chart by Babson and Benda (1976) shows means and standard deviations for birth weight, head circumference, and length from a gestational age of 26 weeks to 1 year of age. • For the newborns, Babson obtained data from mostly Caucasian infants born in Portland, Oregon, for the years from 1959 through 1966. • 39,743 infants with gestational ages from 27 to 44 weeks, including 3381 infants with gestational ages from 27 to 37 weeks were included in the study. • The gestational age was based on the LMP. • Mean and standard deviation for 3 parameters were measured from the chart and were converted into percentiles.
  • 31. Babson and Benda • Limitations- • X axis begins at 26 weeks gestation- limits plotting younger preterms • Y axis has 500gm interval increments-Precise plotting difficult • Small sample size with only 45 babies of 30 weeks or lesser gestation. • 15 years old at time of creating charts and now >50 years old
  • 32. Fenton 2003 Study Meta-analysis of Studies Population The Newborn parameters were based on a. Birth weight- Kramer et al 2001 . USG was used in estimating Gestation age, CDC b. Length and head circumference- Niklasson and Beeby. Gestation- LMP and obstetric assessment. Gestation age between 22 and 50 weeks. Centre Calgary,Canada. Duration 1980 to 2002 Measurements Weight, length and head circumference Data type Cross sectional data predominantly
  • 33.
  • 34. FENTO N Benefits 1. This new fetal-infant chart- updated Babson type 2. This chart will allow a comparison for preterm infants as young as 22 weeks of gestation first with intrauterine and then with post term references and it can replace the one developed by Babson which has been used in neonatal intensive care for over 25 years. 3. The larger sample sizes and more accurate gestational age assignments used here may provide better confidence in the extreme percentiles. 4. It could be used for the assessment of size for gestational age for infants smaller than 2 kilograms. 5. Shows 3, 10, 25, 50, 90 and 97 th Percentiles
  • 35. Disadvantages: 1. Initial parts of the curves are based on the size of fetuses at birth, which do not show the change in weight that occurs after birth. 2. This is followed by curves based on the growth of term infants who have not had the growth depressing effect of prematurity. 3. Predominantly data were cross sectional.- Longitudinal postnatal growth chart- show the pattern of initial weight loss after birth followed by subsequent growth of a sample of preterm infants.
  • 36. Disadvantages: 4. Not based on the growth standard for preterm infants, that is, on fetal growth. Therefore they do not show an infant’s growth velocity or catch-up in growth relative to the fetus or the term infant. 5. Further, the curves on a longitudinal growth chart are highly influenced by the medical and nutritional care of the sample infants; growth patterns may change with innovations in medical and nutritional care 6. Like with all metanalysis , heterogenesity of data sources is a set back.
  • 37. WHO MCGS 2006 Study Recent population based surveys Population The 2006 WHO growth curves for children are based on data from the WHO MGRS, a study conducted in six sites: Pelotas, Brazil; Accra, Ghana; Delhi, India; Oslo, Norway; Muscat, Oman; and Davis, California. Centre Multi-centric Duration 1997-2003 Measurements weight, length and head circumference Data type Longitudinal data
  • 38.
  • 39.
  • 40. Continued Benefits 1. Children from socioeconomic status that does not constrain growth of the child* 2. Six Countries from different continents including both developed and developing countries. 3. Based on population of breast fed babies. The international infant feeding recommendations in effect at the time of the study included exclusive breastfeeding for at least 4 months (although predominantly breastfed infants were also included in the study)# 4. The WHO growth curves for children aged <24 months were based on the longitudinal component of MGRS, in which cohorts of newborns were measured from birth through age 23 months. Longitudinal data were collected at birth, 1 week, and every 2 weeks for the fi rst 2 months after birth, monthly through age 12 months, and bimonthly from age 14 to 24 months
  • 41. Continued Benefits 15. The WHO growth curves for children aged 24-59 months were based on the cross-sectional component MGRS, in which groups of children at specifi c ages were measured at a specifi c point in time. The crosssectional data represented 6,669 children. 6. Data were collected in the same communities as those used to create the curves for children aged <24 months, typically just after completion of the longitudinal study. 7. Other than the infant feeding criteria, the inclusion criteria used for the cross-sectional data collection for ages <24 months and 24-59 months were the same. 8. To eliminate the effect of overweight children on the weight distributions in the WHO curves for children aged 24-59 months, weight measurements of >2 standard deviations above the study median were excluded; a total of 226 (2.7%) weight measurements were excluded.
  • 42. Disadvantages: - Does not address Growth of Preterm infants.
  • 43.
  • 44.
  • 45. Fenton 2013 Study Metanalysis of studies Population Large preterm birth sample size of 4 million infants Data from developed countries including Germany, Italy, United States, Australia, Scotland and Canada Centre Alberta, Canada. Duration 1991 to 2007 Measurements of weight, length and head circumference Data type Cross sectional data for Preterm infants
  • 46.
  • 47.
  • 48. Continued Benefits 1. Based on the recommended growth goal for preterm infants: The fetus and the term infant 2. Girl and boy specific charts 3. Equivalent to the WHO growth charts at 50 weeks gestational age (10 weeks post term age). 4. Large Sample size of 4 million, with large preterm population. 5. More recent Data ( 1991-2007)
  • 49. FENTON Benefits 1. Data from several Developed nations- can be used for both developing and developed. 2. Curves are consistent with the data to 36 weeks, thus can be used to assign size for gestational age up to and including 36 weeks. 3. Chart is designed to enable plotting as infants are measured, not as completed weeks. The x axis adjusted for this chart so that infant size data can be plotted without age adjustment
  • 50. Disadvantages: 1. These growth charts are growth references and are not a growth standard 2. Ideal growth pattern of preterm remains undefined as charts were based on fetal growth and term babies.
  • 51.
  • 52.
  • 53. Intergrowth 21st Chart: For the first time (panel), international standards for newborn size for each gestational age based on data from its NCSS subpopulation, which conformed at population and individual levels to the prescriptive approach used in the WHO MGRS. 1. These new standards - conceptual and practical link to WHO Child Growth Standards, which have been adopted by more than 125 countries worldwide. 2. Gestation age based on USG 3. Included 20,486 eligible women between May 14, 2009, and Aug 2, 2013. 4. Bridges gaps in clinical and population assessments for fetuses, neonatal babies, and infants through provision of similar instruments to monitor child growth seamlessly from early pregnancy to age 5 years and to screen for stunting and wasting.
  • 54. 5 Studies are included in the Project • Fetal Longitudinal Growth Study - a multicentric, population- based assessment of fetal growth in eight countries. • USG was taken for fetal anthropometric measurements prospectively from 14+0 weeks gestation until birth in a cohort of women. women had a reliable estimate of gestational age confirmed by USG measurement of fetal crown–rump length in the first trimester. • The five primary ultrasound measures were obtained every 5 weeks (within 1 week either side) from 14 weeks to 42 weeks of gestation. • The best fitting curves for the five measures were selected using second-degree fractional polynomials and further modelled in a multilevel framework to account for the longitudinal design of the study.
  • 55. • A total 4607 eligible women were included. • A cohort of women with adequate nutrition and health status with less risk of intrauterine growth restriction were selected. • All women had reliable estimate of gestational age confirmed by USG. A 3rd, 5th 10th, 50th, 90th, 95th and 97th centile curves according to gestational age for these ultrasound measures were obtained, representing the international standards for fetal growth . • These international fetal growth standards for the clinical interpretation of routinely taken ultrasound measurements and for comparisons across populations.
  • 56. PPFS and NCSS • For Preterm Postnatal Follow-up Study, all preterm newborns of more than 26 weeks and less than 37 weeks were followed post-delivery for evaluation of postnatal growth. All preterms from FLGS who met criteria of healthy or stable preterm were included. • The Newborn Cross-Sectional Study, a component of intergrowth-21st project, weight, length, and head circumference in all newborn infants were measured, in addition to the data collected prospectively for pregnancy and the perinatal period. Newborn anthropometric measures were obtained within 12 h of birth. A total of 20,486 eligible women were enrolled between May 14, 2009, and Aug 2, 2013. A 3rd, 10th, 50th, 90th, and 97th centile curves were obtained according to gestational age and sex.
  • 57. 5. Software for clinical and epidemiological use free of charge, including an app to calculate Z scores and centiles. 6. The standards are prescriptive—ie, they describe optimum size in newborn infants without congenital abnormalities. 7. These standards are population-based, multiethnic, multicountry, and sex-specific, and they arise from a prospective study.
  • 58. 8.Several processes were applied across all eight study sites— All were uniform and followed a standarized protocol. 9. Present centiles for birthweight, length, and head circumference by sex and gestational age based on a prescriptive approach that are integrated with the corresponding fetal growth standards. 10. The observed and smoothed centiles were almost identical and presented the 3rd, 10th, 50th, 90th, and 97th centile curves according to gestational age and sex.
  • 59. Disadvantages • A shortcoming of studying such a low-risk group is that there were relatively few early preterm births despite the large sample size; hence, we had to limit the range of the standards by setting the lower limit of the curves to those born at 33 weeks of gestation. • It might not be feasible to construct standards for very preterm newborn infants using such a strictly defined subpopulation of preterm babies who are at higher risk of intrauterine growth restriction and other major pregnancy and neonatal complications
  • 60. Time Schedule for Monitoring
  • 61. • Sri Lanka becomes the first country to adopt the INTERGROWTH-21st Preterm Standards • 125 nations have adopted so far

Editor's Notes

  1. Montebellanrd- who plotted his son’s height every six months from birth to age 18 years- Established existence of pubertal growth spurt, seasonal growth variability and Daytime height shrinkage. Philibert Guéneau de Montbeillard, in France, conducted the first study addressing the issue systematically and longitudinally. He analyzed the growth of his son from birth (1759) to 1777 in the form of charts and tables, establishing the existence of the pubertal growth spurt and seasonal changes in growth rates. He also confirmed the occurrence of height “shrinkage” in daytime. It can be considered a very refined work for the time, with good accuracy, although lacking robust statistical analysis or the use of sampling techniques Histoire Naturelle- Encyclopedia
  2. NCHS- which became a part of CDC in 1987,
  3. Calculating Centile- The median is the 50th percentile: the point in the data where 50% of the data fall below that point, and 50% fall above it.  To calculate the kth percentile (where k is any number between zero and one hundred), do the following steps: Order all the values in the data set from smallest to largest. Multiply k percent by the total number of values, n. This number is called the index. If the index obtained in Step 2 is not a whole number, round it up to the nearest whole number and go to Step 4a. If the index obtained in Step 2 is a whole number, go to Step 4b. 4a.Count the values in your data set from left to right (from the smallest to the largest value) until you reach the number indicated by Step 3. The corresponding value in your data set is the kth percentile. 4b.Count the values in your data set from left to right until you reach the number indicated by Step 2. The kth percentile is the average of that corresponding value in your data set and the value that directly follows it. For example, suppose you have 25 test scores, and in order from lowest to highest they look like this: 43, 54, 56, 61, 62, 66, 68, 69, 69, 70, 71, 72, 77, 78, 79, 85, 87, 88, 89, 93, 95, 96, 98, 99, 99. To find the 90th percentile for these (ordered) scores, start by multiplying 90% times the total number of scores, which gives 90% ∗ 25 = 0.90 ∗ 25 = 22.5 (the index). Rounding up to the nearest whole number, you get 23. Counting from left to right (from the smallest to the largest value in the data set), you go until you find the 23rd value in the data set. That value is 98, and it’s the 90th percentile for this data set. Now say you want to find the 20th percentile. Start by taking 0.20 x 25 = 5 (the index); this is a whole number, so proceed from Step 3 to Step 4b, which tells you the 20th percentile is the average of the 5th and 6th values in the ordered data set (62 and 66). The 20th percentile then comes to (62 + 66) ÷ 2 = 64.   The median (the 50th percentile) for the test scores is the 13th score: 77.
  4. lay the child on his back with his head against the fixed headboard, compressing the hair. An imaginary vertical line from the ear canal to the lower border of the eye socket is perpendicular to the board. Standing on the side of the length board where you can see the measuring tape and move the footboard Shoulders should touch the board, and the spine should not be arched. Hold down the child’s legs with one hand and move the footboard with the other. Apply gentle pressure to the knees to straighten the legs. Extremely agitated and both legs cannot be held in position, measure with one leg in position. The soles of the feet should be flat against the footboard, toes pointing upwards. If the child bends the toes and prevents the footboard from touching the soles, scratch the soles slightly and slide in the footboard quickly when the child straightens the toes.
  5. National Institute of Child Health and Human Development
  6. Maximum weight loss, time taken to regain birth weight and later weight gain pattern followed the Ehrenkranz postnatal growth curves except in infants with birth weight below 1000 g who experienced slower growth (Fig. 3)(7). The length and HC in this cohort were higher at birth and fell well below respective reference lines by discharge, except in infants with birthweight more than 1200g.
  7. *(based on infant mortality rate; prevalence of underweight, stunting, and wasting; subpopulation size; and access to safewater #, introduction of complementary foods by at least 6 months but not before 4 months, and continued breastfeeding for at least 12 months.
  8. *(based on infant mortality rate; prevalence of underweight, stunting, and wasting; subpopulation size; and access to safewater #, introduction of complementary foods by at least 6 months but not before 4 months, and continued breastfeeding for at least 12 months.
  9. 1. as other resource factors do not affect growth
  10. eg, uniform research methods and one protocol for gestational age estimation by ultrasound for all participants, plus standardised identical equipment, training, a centralised electronic data management system, and close monitoring of staff, which, to our knowledge, have never before been attempted in perinatal research.